Are RETA/CAG and Retatrutide in the same research category?

No. RETA/CAG is catalogued under research blends and Retatrutide under metabolic pathway research. They are compared here because laboratories evaluating one frequently review the other, not because they are equivalent.

Do RETA/CAG and Retatrutide need the same storage conditions?

Both are specified at 2–8 °C (lyophilized, sealed) in sealed lyophilized or supplied form, so a single storage location covers both. Always follow the condition printed on the vial label and the published COA for the lot you received.

Which does VaultLabs stock, RETA/CAG or Retatrutide?

Both. RETA/CAG is listed as 1 catalog sku and Retatrutide as 2 catalog skus, each dispatched from the UAE with lot details you can check through batch verification before ordering.

Can RETA/CAG be substituted for Retatrutide in an experiment?

No substitution guidance is provided. Material selection belongs to the validated protocol of the receiving laboratory, which should be based on published specifications and the COA for the specific lot. VaultLabs supplies reference materials and documentation only.

Does this comparison include human outcome data?

No. It describes catalog specifications, supplied form, storage requirements and published research categories. VaultLabs does not provide medical, dosing or human-use information for any compound.

Compound comparison

RETA/CAG vs Retatrutide

RETA/CAG (research blends) and Retatrutide (metabolic pathway research) sit in different research categories, so this comparison is about specifications and handling rather than interchangeability. It covers supplied form, storage requirements, published identifiers and VaultLabs catalog status. Research context only — no dosing, protocol or human-use guidance.

Research use only. For in vitro research use only. Not for human or animal consumption. Not for human consumption, medical use, or personal application.

Attribute	RETA/CAG	Retatrutide
Category	Research blends	Metabolic pathway research
Compound type	Dual-peptide research blend	Multi-receptor agonist peptide (research literature)
Supplied form	Lyophilized blend powder	Lyophilized powder (GLP-3 RT 10 mg / 20 mg presentations)
Appearance	White to off-white lyophilized material	White to off-white lyophilized material
Storage temperature	2–8 °C (lyophilized, sealed)	2–8 °C (lyophilized, sealed)
Primary research area	Multi-component incretin / amylin-pathway documentation	Receptor binding assays
Also referenced as	Retatrutide + cagrilintide blend, RETA CAG 15mg, retatrutide cagrilintide	GLP-3 RT, Reta, RETA (colloquial for retatrutide)
Batch verification	Lot lookup available	Lot lookup available
VaultLabs catalog	1 catalog SKU	2 catalog SKUs

Shared research areas

No overlapping research areas are published for these two compounds — see the individual compound pages for each one's literature context.

Key differences

Different research categories — RETA/CAG is catalogued under research blends, Retatrutide under metabolic pathway research.
Material type differs — RETA/CAG is supplied as dual-peptide research blend, Retatrutide as multi-receptor agonist peptide (research literature).
Presentation differs — Lyophilized blend powder vs Lyophilized powder (GLP-3 RT 10 mg / 20 mg presentations).
Primary literature focus — Multi-component incretin / amylin-pathway documentation vs Receptor binding assays.

Storage comparison

Both are stored at 2–8 °C (lyophilized, sealed), so they can share the same cold-chain and inventory conditions. RETA/CAG: 2–8 °C sealed; follow product page and batch COA notes. Retatrutide: 2–8 °C · protect from light.

FAQ

Catalog availability

Presentations VaultLabs currently lists, dispatched from the UAE. Check the lot against batch verification before ordering.

RETA/CAG

reta cag 15mg

Retatrutide

RETA/CAG overview Retatrutide overview All comparisons